These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Therapeutic potential of targeting oxidative stress in diabetic cardiomyopathy. Byrne NJ; Rajasekaran NS; Abel ED; Bugger H Free Radic Biol Med; 2021 Jun; 169():317-342. PubMed ID: 33910093 [TBL] [Abstract][Full Text] [Related]
4. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy. Palomer X; Salvadó L; Barroso E; Vázquez-Carrera M Int J Cardiol; 2013 Oct; 168(4):3160-72. PubMed ID: 23932046 [TBL] [Abstract][Full Text] [Related]
6. Conundrum of pathogenesis of diabetic cardiomyopathy: role of vascular endothelial dysfunction, reactive oxygen species, and mitochondria. Joshi M; Kotha SR; Malireddy S; Selvaraju V; Satoskar AR; Palesty A; McFadden DW; Parinandi NL; Maulik N Mol Cell Biochem; 2014 Jan; 386(1-2):233-49. PubMed ID: 24307101 [TBL] [Abstract][Full Text] [Related]
7. Clinical Approach to Diabetic Cardiomyopathy: A Review of Human Studies. Tarquini R; Pala L; Brancati S; Vannini G; De Cosmo S; Mazzoccoli G; Rotella CM Curr Med Chem; 2018; 25(13):1510-1524. PubMed ID: 28685679 [TBL] [Abstract][Full Text] [Related]
8. Mitochondrial ROS Formation in the Pathogenesis of Diabetic Cardiomyopathy. Kaludercic N; Di Lisa F Front Cardiovasc Med; 2020; 7():12. PubMed ID: 32133373 [TBL] [Abstract][Full Text] [Related]
9. NADPH oxidases and cardiac remodelling. Nabeebaccus A; Zhang M; Shah AM Heart Fail Rev; 2011 Jan; 16(1):5-12. PubMed ID: 20658317 [TBL] [Abstract][Full Text] [Related]
10. Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes. Huynh K; Kiriazis H; Du XJ; Love JE; Jandeleit-Dahm KA; Forbes JM; McMullen JR; Ritchie RH Diabetologia; 2012 May; 55(5):1544-53. PubMed ID: 22374176 [TBL] [Abstract][Full Text] [Related]
12. EGFR inhibition protects cardiac damage and remodeling through attenuating oxidative stress in STZ-induced diabetic mouse model. Liang D; Zhong P; Hu J; Lin F; Qian Y; Xu Z; Wang J; Zeng C; Li X; Liang G J Mol Cell Cardiol; 2015 May; 82():63-74. PubMed ID: 25758431 [TBL] [Abstract][Full Text] [Related]
13. The Role of Heme Oxygenase 1 in the Protective Effect of Caloric Restriction against Diabetic Cardiomyopathy. Waldman M; Nudelman V; Shainberg A; Zemel R; Kornwoski R; Aravot D; Peterson SJ; Arad M; Hochhauser E Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31100876 [TBL] [Abstract][Full Text] [Related]
14. FT011, a new anti-fibrotic drug, attenuates fibrosis and chronic heart failure in experimental diabetic cardiomyopathy. Zhang Y; Edgley AJ; Cox AJ; Powell AK; Wang B; Kompa AR; Stapleton DI; Zammit SC; Williams SJ; Krum H; Gilbert RE; Kelly DJ Eur J Heart Fail; 2012 May; 14(5):549-62. PubMed ID: 22417655 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic targeting of oxidative stress with coenzyme Q10 counteracts exaggerated diabetic cardiomyopathy in a mouse model of diabetes with diminished PI3K(p110α) signaling. De Blasio MJ; Huynh K; Qin C; Rosli S; Kiriazis H; Ayer A; Cemerlang N; Stocker R; Du XJ; McMullen JR; Ritchie RH Free Radic Biol Med; 2015 Oct; 87():137-47. PubMed ID: 25937176 [TBL] [Abstract][Full Text] [Related]
16. Akap1 deficiency exacerbates diabetic cardiomyopathy in mice by NDUFS1-mediated mitochondrial dysfunction and apoptosis. Qi B; He L; Zhao Y; Zhang L; He Y; Li J; Li C; Zhang B; Huang Q; Xing J; Li F; Li Y; Ji L Diabetologia; 2020 May; 63(5):1072-1087. PubMed ID: 32072193 [TBL] [Abstract][Full Text] [Related]
17. Oxidative stress and redox signalling in cardiac hypertrophy and heart failure. Seddon M; Looi YH; Shah AM Heart; 2007 Aug; 93(8):903-7. PubMed ID: 16670100 [TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of hypertension--reactive oxygen species and antioxidants: a basic science update for the clinician. Montezano AC; Touyz RM Can J Cardiol; 2012 May; 28(3):288-95. PubMed ID: 22445098 [TBL] [Abstract][Full Text] [Related]
19. Oxidative stress and heart failure. Byrne JA; Grieve DJ; Cave AC; Shah AM Arch Mal Coeur Vaiss; 2003 Mar; 96(3):214-21. PubMed ID: 12722552 [TBL] [Abstract][Full Text] [Related]
20. Reactive oxygen species, mitochondria, and NAD(P)H oxidases in the development and progression of heart failure. Sorescu D; Griendling KK Congest Heart Fail; 2002; 8(3):132-40. PubMed ID: 12045381 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]